OR

Browse By

Phase 2 clinical study for a next-generation, needle free COVID-19 vaccine CRC-P administered by Vaxxas Pty Ltd) (2023–2025)

Grant type:
Vaxxas Pty Ltd
Researchers:

  • Associate Professor David Muller

    Principal Research Fellow
    School of Chemistry and Molecular Biosciences
    Faculty of Science

  • Professor Paul Young

    Professor, Research Development
    Office of the Deputy Vice-Chancellor (Research and Innovation)
    Affiliate Professor
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
Vaxxas Pty Ltd